References
- Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57: 2006-2021. https://doi.org/10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6
- Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, et al. Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer 1981; 47: 2503-2509. https://doi.org/10.1002/1097-0142(19810515)47:10<2503::AID-CNCR2820471033>3.0.CO;2-3
- Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002; 62: 1573-1577.
- Hrehorovich PA, Franke HR, Maximin S, Caracta P. Malignant peripheral nerve sheath tumor. Radiographics 2003; 23: 790-794. https://doi.org/10.1148/rg.233025153
- Perrin RG, Guha A. Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am 2004; 15: 203-216. https://doi.org/10.1016/j.nec.2004.02.004
- Adamson DC, Cummings TJ, Friedman AH. Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Clin Neuropathol 2004; 23: 245-255.
- Amin A, Saifuddin A, Flanagan A, Patterson D, Lehovsky J. Radiotherapy-induced malignant peripheral nerve sheath tumor of the cauda equina. Spine 2004; 29: E506-E509. https://doi.org/10.1097/01.brs.0000143168.87295.ca
- Bhattacharyya AK, Perrin R, Guha A. Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol 2004; 69: 335-349. https://doi.org/10.1023/B:NEON.0000041891.39474.cb
- Vauthey JN, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol 1995; 2: 126-131. https://doi.org/10.1007/BF02303627
- Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 2003; 61: 696-698. https://doi.org/10.1212/01.WNL.0000078813.05925.2C
- Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol 2003; 10: 432-440. https://doi.org/10.1245/ASO.2003.05.014
- Storm FK, Eilber FR, Mirra J, Morton DL. Neurofibrosarcoma. Cancer 1980; 45: 126-129. https://doi.org/10.1002/1097-0142(19800101)45:1<126::AID-CNCR2820450122>3.0.CO;2-U
- Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 1990; 66: 1253-1265. https://doi.org/10.1002/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R
- Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006; 107: 1065-1074. https://doi.org/10.1002/cncr.22098
- Doorn PF, Molenaar WM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 1995; 21: 78-82. https://doi.org/10.1016/S0748-7983(05)80073-3
- Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 1993; 71: 1247-1253. https://doi.org/10.1002/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S
- Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 1998; 42: 351-360.
- Garg A, Gupta V, Gaikwad SB, Mishra NK, Ojha BK, Chugh M, et al. Scalp malignant peripheral nerve sheath tumor (MPNST) with bony involvement and new bone formation: case report. Clin Neurol Neurosurg 2004; 106: 340-344. https://doi.org/10.1016/j.clineuro.2004.01.003
Cited by
- Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis vol.154, pp.2, 2021, https://doi.org/10.1007/s11060-021-03826-3